2-氨基-4-噻唑乙酸乙酯
2-氨基-4-噻唑乙酸乙酯结构式
|
常用名 | 2-氨基-4-噻唑乙酸乙酯 | 英文名 | Ethyl (2-amino-1,3-thiazol-4-yl)acetate |
|---|---|---|---|---|
| CAS号 | 53266-94-7 | 分子量 | 186.232 | |
| 密度 | 1.3±0.1 g/cm3 | 沸点 | 318.5±17.0 °C at 760 mmHg | |
| 分子式 | C7H10N2O2S | 熔点 | 92-94 °C(lit.) | |
| MSDS | 美版 | 闪点 | 146.4±20.9 °C |
|
Dichloridobis[ethyl 2-(2-amino-1,3-thia-zol-4-yl)acetate-κ(2)O,N(3)]cadmium.
Acta Crystallogr. Sect. E Struct. Rep. Online 68(6) , m788-m789, (2012) The asymmetric unit of the title compound, [CdCl(2)(C(7)H(10)N(2)O(2)S)(2)], contains two complex molecules with similar configurations. The Cd(II) atoms are each six-coordinated by two thiazole N and two carbonyl O atoms from the 2-(2-amino-1,3-thiazol-4-yl)... |
|
|
Bis(2-amino-thia-zole-4-acetato)aquazinc(II).
Acta Crystallogr. Sect. E Struct. Rep. Online 65(12) , m1517-m1517, (2009) In the title compound, [Zn(C(5)H(5)N(2)O(2)S)(2)(H(2)O)], the central Zn atom (2 site symmetry) is five-coordinated by two N and three O atoms [Zn-N = 2.047 (3) Å, Zn-O = 2.099 (2) and 1.974 (4) Å] in a distorted square-pyramidal geometry. Besides one O atom ... |
|
|
Discovery of 3-(4-methanesulfonylphenoxy)-N-[1-(2-methoxy-ethoxymethyl)-1H-pyrazol-3-yl]-5-(3-methylpyridin-2-yl)-benzamide as a novel glucokinase activator (GKA) for the treatment of type 2 diabetes mellitus
Bioorg. Med. Chem. 22(7) , 2280-93, (2014) Novel heteroaryl-containing benzamide derivatives were synthesized and screened using an in vitro assay measuring increases in glucose uptake and glucokinase activity stimulated by 10mM glucose in rat hepatocytes. From a library of synthesized compounds, 3-(4... |